Common use

Fenofibrate is a lipid-regulating medication belonging to the fibrate drug class, widely prescribed to manage abnormal cholesterol and triglyceride levels in the blood. The active substance, fenofibrate, is a prodrug that undergoes conversion in body tissues to its active metabolite, fenofibric acid, which is responsible for the medication's therapeutic effects. Fenofibrate is used in conjunction with a proper diet to treat patients with very high triglyceride levels (hypertriglyceridemia), mixed dyslipidemia, and primary hypercholesterolemia.

The mechanism of action of Fenofibrate involves activation of peroxisome proliferator-activated receptor alpha (PPAR-alpha), which in turn increases the activity of lipoprotein lipase — the enzyme responsible for breaking down triglyceride-rich lipoproteins. Fenofibrate accelerates the catabolism of triglycerides in very low-density lipoproteins (VLDL), promotes the transfer of cholesterol from atherogenic VLDL to antiatherogenic high-density lipoproteins (HDL), and decreases hepatic synthesis of VLDL particles. The result is a significant reduction in total triglycerides, LDL cholesterol, and total cholesterol, along with a beneficial increase in HDL ("good") cholesterol. Buy Fenofibrate online for effective, affordable management of high cholesterol and triglyceride disorders.



Dosage and direction

Take Fenofibrate orally as directed by your physician. For the treatment of high cholesterol levels or a combination of high cholesterol and high triglycerides, the typical initial dose is 160 mg taken once daily with a meal. Taking Fenofibrate with food significantly enhances absorption and bioavailability of the medication.

For the treatment of elevated triglyceride levels alone, the starting dose of Fenofibrate ranges from 54 to 160 mg per day, depending on the specific formulation prescribed. Your doctor may gradually adjust the dose every 4 to 8 weeks based on your lipid panel results, up to a maximum effective dose of 160 mg per day. Regular blood tests to monitor cholesterol, triglyceride levels, and liver function are essential during Fenofibrate therapy to ensure optimal treatment response and safety.



Precautions

Liver function should be monitored regularly through blood tests (transaminase levels) in all patients taking Fenofibrate. If blood tests reveal ALT levels increasing to more than twice the upper limit of normal and are accompanied by symptoms such as muscle pain (myalgia) and muscle weakness, Fenofibrate treatment should be discontinued immediately and your doctor consulted.

Fenofibrate treatment must always be combined with a proper hypolipidemic (cholesterol-lowering) diet and should be undertaken only under the supervision of a healthcare provider. Treatment typically requires long-term commitment for sustained benefit. Be aware that Fenofibrate has the potential to increase the risk of gallstone formation (cholelithiasis), particularly during the first year of treatment. Report any symptoms of abdominal pain, nausea, or bloating to your doctor promptly, as these could indicate gallbladder complications.



Contraindications

Fenofibrate is contraindicated in patients with known hypersensitivity to fenofibrate, fenofibric acid, or any inactive component of the medication. It should not be used in patients with severe hepatic impairment, severe renal dysfunction, pre-existing gallbladder disease, or unexplained persistent liver function abnormalities. Fenofibrate is contraindicated during pregnancy and breastfeeding due to potential risks to the developing fetus or nursing infant.



Possible side effect

Fenofibrate may cause a range of side effects. More serious adverse reactions that require immediate medical attention include: cholelithiasis (gallstones); elevated liver transaminases or creatine kinase levels; severe nausea, vomiting, or persistent diarrhea; myalgia (muscle pain), myositis (muscle inflammation), or rhabdomyolysis (a serious condition involving rapid breakdown of skeletal muscle tissue that can lead to kidney damage); acute renal failure; severe dizziness or persistent headache; significant abdominal or back pain; unusual fatigue or weakness; sexual dysfunction including impotence; and widespread skin rash or allergic reactions.

If you experience any of these symptoms, contact your healthcare provider immediately. Less common side effects include mild digestive discomfort, respiratory infections, and joint pain. Regular monitoring of blood tests during treatment helps detect potential complications early.



Drug interaction

Inform your doctor about all prescription and over-the-counter medications, vitamins, and supplements you are currently taking before starting Fenofibrate therapy. Important drug interactions to be aware of include: blood thinners such as warfarin (Coumadin) — Fenofibrate may enhance anticoagulant effects and increase bleeding risk, requiring more frequent INR monitoring; cyclosporine (an immunosuppressant used after organ transplantation); MAO inhibitors including selegiline, furazolidone, tranylcypromine, phenelzine, and moclobemide; diabetic medications such as glipizide and insulin — Fenofibrate may enhance their blood sugar-lowering effects; estrogens and oral contraceptives; and statin medications (lovastatin, pravastatin, simvastatin, atorvastatin) and high-dose niacin (1 gram or more per day).

The combination of Fenofibrate with statins or high-dose niacin carries an increased risk of myopathy (muscle injury) and rhabdomyolysis. If combination therapy is deemed necessary, your doctor will closely monitor you for signs of muscle toxicity.



Missed dose

If you forget to take your scheduled dose of Fenofibrate, take it as soon as you remember. However, if it is nearly time for your next dose, skip the missed dose and continue with your regular schedule. Do not take a double dose to make up for the missed one. Resume your usual dosing routine the following day at your regular time.



Overdose

Any medication taken in excessive amounts can be potentially dangerous. If you suspect a Fenofibrate overdose, seek immediate medical attention by contacting your doctor, visiting the nearest emergency room, or calling your local poison control center. Prompt medical evaluation is important even if no symptoms are immediately apparent.



Storage

Store Fenofibrate at room temperature between 59-77 F (15-25 C) in a dry location away from direct light, excessive heat, and moisture. Keep the medication in its original container and out of reach of children and pets. Do not use Fenofibrate after the expiration date printed on the packaging.



Disclaimer

We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.